Evaluation of ClearLLab LS Screening Panel

CompletedOBSERVATIONAL
Enrollment

831

Participants

Timeline

Start Date

May 25, 2023

Primary Completion Date

October 15, 2024

Study Completion Date

November 18, 2024

Conditions
Hematologic MalignancyHematologic NeoplasmsHematologic Diseases
Interventions
DIAGNOSTIC_TEST

Flow Cytometry

Immunophenotyping of residual clinical samples tested with ClearLLab LS screening panel on a specified Flow Cytometry

Trial Locations (4)

Unknown

Tongji Hospital, Wuhan

The First Affiliated Hospital of Nanjing Medical University, Nanjing

The First Affiliated Hospital of Soochow University, Suzhou

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin

Sponsors
All Listed Sponsors
collaborator

Institute of Hematology & Blood Diseases Hospital, China

OTHER

collaborator

The First Affiliated Hospital of Soochow University

OTHER

collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Tongji Hospital

OTHER

lead

Beckman Coulter, Inc.

INDUSTRY